Collaboration will Leverage Solidion’s Patent Portfolio and Drive U.S. Manufacturing DALLAS, Nov. 11, 2024 /PRNewswire/ — Solidion Technology, Inc. (NASDAQ:…
Nominated IDE034 (BCG034) as a development candidate, a potential first-in-class B7H3/PTK7 topo-I-payload bispecific antibody drug conjugate (BsADC) Option exercised for…